Articles From: Rebalancing Made Simple to Relypsa Announces Commercial Manufacturing Agreement With DSM Fine Chemicals


2011/10/20
A step-by-step guide to restoring your asset allocation.
Sign-up for Rebalancing Made Simple investment picks
SAN DIEGO, April 28, 2014 (GLOBE NEWSWIRE) -- Receptos Inc. (Nasdaq:RCPT) today announced that Company personnel will deliver two scientific poster presentations regarding its lead program, RPC1063, at the annual meeting of the American Academy of Neurology (AAN) in Philadelphia, PA.
Sign-up for Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting investment picks
SAN DIEGO, May 7, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, will announce financial results for the first quarter ended March 31, 2014 on Monday, May 12 before the markets open.
Sign-up for Receptos to Hold First Quarter 2014 Financial Results Conference Call and Webcast investment picks
SAN DIEGO, May 6, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that management will be presenting at the Bank of America Merrill Lynch 2014 Health Care Conference at the Encore Hotel in Las Vegas.
Sign-up for Receptos to Present at Bank of America Merrill Lynch 2014 Health Care Conference investment picks
SAN DIEGO, May 1, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that its Chief Financial Officer, Graham Cooper, will be presenting at the Deutsche Bank Securities Annual Healthcare Conference at the InterContinental Hotel in Boston.
Sign-up for Receptos to Present at Deutsche Bank Securities Annual Healthcare Conference investment picks
BEIJING , May 15, 2014 /PRNewswire/ -- Recon Technology, Ltd.
Sign-up for Recon Technology Announces 143% Increase in Third Quarter Revenue investment picks
2014/5/15
New England's Largest Theme Park Introduces the Tallest Swing Ride on the Planet AGAWAM, Mass.
Sign-up for Record-Breaking "New England SkyScreamer" is Now Open at Six Flags New England investment picks
2014/5/13
http://media.marketwire.com/attachments/201206/55916_RGEMarketwireLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1115101&ProfileId=051205&sourceType=1 ORLANDO, FL --
Sign-up for Red Giant Entertainment to Attend 'E3 2014,' Premier Gaming Trade Show in Los Angeles in June investment picks
SPOKANE, Wash., April 28, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) has earned a 2014 Visionary Award from Hospitality Technology (HT) magazine for its complete rewrite of all public-facing technologies in the consumer website.
Sign-up for Red Lion Earns National Award for Customer-Facing Technology investment picks
SPOKANE, Wash., May 21, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) announced the company has named Brian Quinn as Senior Vice President and Chief Franchise Officer.
Sign-up for Red Lion Hotels Appoints Brian Quinn as Chief Franchise Officer investment picks
SPOKANE, Wash., April 30, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) , a western U.S. based owner, operator and franchisor of midscale hotels, today announced its results for the first quarter ended March 31, 2014.
Sign-up for Red Lion Hotels Reports First Quarter 2014 Results investment picks
SPOKANE, WA, May 7, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) announced today its franchise hotel, the Red Lion Inn & Suites Kennewick, was recently sold and the new owner has entered into a franchise agreement to continue to operate the hotel under the brand.
Sign-up for Red Lion Hotels Signs New Franchise Agreement for Red Lion Inn & Suites Kennewick investment picks
SPOKANE, WASH., May 5, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) has entered into an agreement with Sceptre Hospitality Resources (SRH) to configure WindsurferCRS as the premise of its reservation platform and provide unprecedented access to reservation, distribution and reporting information.
Sign-up for Red Lion Hotels to Deploy New Central Reservation System Powered by WindsurferCRS investment picks
SPOKANE, WA, May 22, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) announced the company has sold its property in Kelso/Longview, Wash., to new owners who signed a franchise agreement with a property improvement plan.
Sign-up for Red Lion Sells Kelso Hotel and Enters into Franchise Agreement investment picks
Enables lower pressures over the course of the night than standard APAP SAN DIEGO , May 21, 2014 /PRNewswire/ -- A new study presented today at the American Thoracic Society 2014 International Conference (Abstract #714) indicates that a new algorithm developed specifically for how female sleep apnea sufferers breathe and who use auto-adjusting positive airway pressure (APAP) therapy can improve flow limitation and enable lower pressures for therapy, leading to a more comfortable therapy experience.
Sign-up for Redefining Sleep Apnea Treatment for Women: New Algorithm Significantly Improves Treatment of Flow Limitation investment picks
FDA's clearance of RedHill's Investigational New Drug ("IND") amendment allows the initiation of a Phase III clinical study for a new undisclosed indication with RHB-102 1 , a proprietary, once-daily, extended release oral pill formulation of the antiemetic drug ondansetron In parallel to pursuing the new undisclosed indication, RedHill is pursuing marketing approval of RHB-102 for the indications of chemotherapy and radiotherapy-induced nausea and vomiting ("CINV" and "RINV" respectively) in Europe and the U.S. TEL-AVIV, Israel, May 22, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Announces FDA Clearance for Phase III Study With RHB-102 Planned to Commence in Q3/2014 investment picks
Key financial highlights include: TEL-AVIV, Israel, April 30, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Reports Results for the First Quarter of 2014 investment picks
RedHill received positive results from a comparative bioavailability clinical trial which included 20 healthy volunteers In light of the positive results, and subject to regulatory requirements, the Company plans to submit, during the third quarter of this year, a European marketing application for RHB-102 for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting in cancer patients RHB-102 is a proprietary, once-daily, extended release oral pill formulation of the anti-emetic oncology support drug ondansetron RedHill is also pursuing a new undisclosed indication for RHB-102, which may significantly expand its potential market, with a Phase III study planned to commence in the U.S. later this year TEL-AVIV, Israel, April 30, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Reports Successful RHB-102 Bioavailability Clinical Trial and Planned Submission of European Marketing Application in Q3/2014 investment picks
TEL-AVIV, Israel, April 29, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma to Host First Quarter 2014 Financial Results Conference Call on May 1, 2014 investment picks
TEL-AVIV, Israel, May 1, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma to Present at the ChinaBio Partnering Forum 2014 investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Declares $0.28 Per Share Dividend For The Second Quarter Of 2014 investment picks
2014/5/7
SARASOTA, Fla., May 7, 2014 (GLOBE NEWSWIRE) -- Caribbean International Holdings (Pink Sheets:CIHN) through its subsidiary, Regenerative BioScience, Inc., ("RBS") today announced that a noted member of its Advisory Board and a scientific advisor for Regenerative Biosciences, Rafael Gonzalez, Ph.D. has been conducting negotiations on the Company's behalf with a California based "stem cell banking" company.
Sign-up for Regenerative BioScience, Inc., a Wholly Owned Subsidiary of Caribbean International Holdings (CIHN), Announces Its Plans to Enter Into Strategic Alliance to Store Stem Cells for Future Use investment picks
NEW YORK, May 20, 2014 (GLOBE NEWSWIRE) -- Reis, Inc. (Nasdaq:REIS) ("Reis" or the "Company"), a leading provider of commercial real estate market information and analytical tools, announced today that on May 19, 2014 its Board of Directors approved the initiation of a program of paying a regular quarterly cash dividend to the Company's shareholders.
Sign-up for Reis, Inc. Announces First Ever Quarterly Cash Dividend investment picks
NEW YORK, May 5, 2014 (GLOBE NEWSWIRE) -- Reis, Inc. (Nasdaq:REIS) (Reis or the Company), the most trusted provider of commercial real estate market information and analytical tools, today announced the launch of the nation's first independent coverage of the Seniors Housing sector.
Sign-up for Reis, Inc. Launches Enhanced Coverage of Seniors Housing Sector investment picks
NEW YORK, April 28, 2014 (GLOBE NEWSWIRE) -- Reis, Inc. (Nasdaq:REIS) ("Reis" or the "Company"), a leading provider of commercial real estate market information and analytical tools, announced that it will release its first quarter 2014 results on the morning of Thursday, May 1, 2014.
Sign-up for Reis, Inc. to Announce First Quarter 2014 Results on Thursday, May 1, 2014 investment picks
NEW YORK, May 12, 2014 (GLOBE NEWSWIRE) -- Reis, Inc. (Nasdaq:REIS) ("Reis" or the "Company"), a leading provider of commercial real estate market information and analytical tools, today announced that Lloyd Lynford, President and Chief Executive Officer, will present at the B.
Sign-up for Reis, Inc. to Present at B. Riley & Co. 15th Annual Investor Conference investment picks
2014/5/20
Kicking off the summer travel season, ExtraCare members can earn free $10 gas cards when spending $30 on everyday essentials advertised in the circular WOONSOCKET, R.I. , May 20, 2014 /PRNewswire/ -- Just in time for Memorial Day weekend and the unofficial start of summer, CVS/pharmacy today announced the return of the "Free Gas Card" promotion, a program designed to help customers save on gas while shopping for everyday essentials at participating CVS/pharmacy locations nationwide.
Sign-up for Relief at the Pump: CVS/pharmacy Announces Return of "Free Gas Card" Promotion investment picks
REDWOOD CITY, Calif., May 20, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) , a biopharmaceutical company, today announced that it has entered into a multi-year commercial manufacturing and supply agreement with DSM Fine Chemicals Austria NFG GMBH & Co.
Sign-up for Relypsa Announces Commercial Manufacturing Agreement With DSM Fine Chemicals investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Rebalancing Made Simple to Relypsa Announces Commercial Manufacturing Agreement With DSM Fine Chemicals
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry